Navigation Links
Hill-Rom Announces Third Quarter 2010 Dividend
Date:5/7/2010

BATESVILLE, Ind., May 7 /PRNewswire-FirstCall/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) today announced its fiscal 2010 third quarter dividend of $0.1025 per share. This dividend was declared by Hill-Rom's Board of Directors on May 6, 2010, and is payable on June 30, 2010, to shareholders of record as of June 16, 2010.  

ABOUT HILL-ROM HOLDINGS, INC.

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and information technology solutions.  Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom...enhancing outcomes for patients and their caregivers.

www.hill-rom.com


'/>"/>
SOURCE Hill-Rom Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Hill-Rom to Present at the Bank of America Merrill Lynch 2010 Health Care Conference
2. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2010 Second Quarter Earnings Webcast
3. Hill-Rom Extends Smart Bed Features for High-Tech Hospital Rooms
4. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
5. Hill-Rom Introduces Smart Bed Technology into CareAssist(R) ES Bed
6. Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter
7. Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies
8. Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings
9. Hill-Rom Announces Appointment of James R. Giertz to Board of Directors
10. Hill-Rom to Host Investors Conference in New York City
11. Hill-Rom and Encompass Group Form Joint Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...   Mast Therapeutics, Inc. (NYSE MKT: ... Santosh Vetticaden, Chief Medical Officer and Senior Vice ... reasons, in mid-September.  Edwin L. Parsley , ... which Mast acquired earlier this year, will assume ... Chief Medical Officer.  Dr. Parsley previously was with ...
(Date:8/29/2014)... Research and Markets has announced ... Market & Pipeline Insight 2014" report to their ... prevent and eradicate the prevalence of cancer have achieved ... to low specificity, safety and large number of side ... better solution. It has been discovered that peptides can ...
(Date:8/29/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... District of New Jersey has ... Sandoz, Inc. regarding United Therapeutics, Remodulin ® product.  In ... U.S. Patent No. 6,765,117 is both valid and enforceable ... generic product until the expiration of that patent in ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2
... off daily GERD medication at 1 year ... after transoral incisionless fundoplication surgery, REDMOND, Wash., ... natural orifice surgery products and procedures, announces,outstanding results ... patients,in the phase 2 multi-center study of the ...
... Dong-A PharmTech Co., Ltd.,announced today that its ... patient, phase 2 proof of concept clinical study ... phosphodiesterase type 5 inhibitor, for,portal hypertension, an unmet ... investigate the safety and efficacy of udenafil in ...
Cached Medicine Technology:EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study 2EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study 3EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study 4Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil 2Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil 3
(Date:8/29/2014)... regarded audiologist , Dr. Mary Ann Larkin has written 4 ... are titled:, , Revealing the Truth About Tinnitus ... The Top 5 Things You Should Know Before Buying a ... , Dr. Mary Anne Larkin choose to write about ... misinformation about each them. The reports are available for immediate ...
(Date:8/29/2014)... Pursuing its deepest desires to help build ... stunning new design that promises to redefine the global ... surrogacy platform has witnessed a 42 percent increase in ... month, the FindSurrogateMother.com community is formed by hopeful parents ... — the precious gift of life. , Whether intended ...
(Date:8/29/2014)... Aug. 29, 2014 (HealthDay News) -- If you have bunions, ... serious treatment later, an expert says. A bunion is ... toe when bone or tissue moves out of place and ... bunions can cause debilitating pain and may require surgery to ... CentraState Medical Center in Freehold, N.J. To prevent bunions, ...
(Date:8/29/2014)... 29, 2014 - Despite US Preventive Services Task Force ... barriers, several of which may be ameliorated through technological ... NYU Langone Medical Center published online August 21, 2014 ... ( JGIM ). , David Levine, MD, MA, a ... at NYU Langone, and colleagues found that compared to ...
(Date:8/29/2014)... (Sept. 2, 2014) A team of scientists from ... the breakthrough discovery of a process to expand production ... findings could have implications that extend beyond cancer, including ... diseases., In an article published Aug. 29 ... C. Gates Center for Regenerative Medicine and Stem Cell ...
Breaking Medicine News(10 mins):Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Take Steps to Control Bunions 2Health News:Options for weight loss your primary care doctor might not know about 2Health News:CU scientists' discovery could lead to new cancer treatment 2
... Today at 9:00am ET , , Covers Europe, ... , , Includes Licensing Option and ... Calif. and STAINES, England, June 22 NeurogesX, Inc. (Nasdaq: ... Tokyo based Astellas Pharma Inc. announced today that the companies have entered ...
... ... company , ... Colo. (PRWEB) June 22, 2009 -- Silver Creek Systems®, the pioneer and ... that their DataLens™ System was selected by McKesson Medical-Surgical to automate the processes that ...
... "Anesthesia & Me"(C) Checklist to Help Patients Organize ... , LifelinetoModernMedicine.com Provides Patients with Physician-Certified Tools ... 22 Every year, 46 million Americans face ... help educate and inform prospective patients and the ...
... self-help technique called guided imagery has been steadily gaining ... insurance companies, as new research demonstrates its efficacy for ... June 22 A new self-help audio recording designed ... or other viral and bacterial illnesses was released this ...
... June 22 /PRNewswire-Asia/ -- The Healthcare & Science,business ... a Memorandum of,Understanding (MOU) with the Science & ... organization under the National,Applied Research Laboratories in Taiwan, ... Taiwan,s Science & Technology (S&T) development. , ...
... , ... resource in the compounding pharmacy industry had just been released by Esco. The videos ... ... announces the release of its new series of safety and education videos for the ...
Cached Medicine News:Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 2Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 3Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 4Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 5Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 6Health News:McKesson Medical-Surgical Selects DataLens System to Automate Product Data Mastering 2Health News:American Society of Anesthesiologists Launches Web Site Focused on Educating and Empowering the Public about Anesthesiology 2Health News:American Society of Anesthesiologists Launches Web Site Focused on Educating and Empowering the Public about Anesthesiology 3Health News:Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning 2Health News:Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning 3Health News:Taiwan's Science & Technology Policy Research and Information Center (STPI) and Thomson Reuters Sign MOU of Collaboration to Support Science & Technology Development 2Health News:Taiwan's Science & Technology Policy Research and Information Center (STPI) and Thomson Reuters Sign MOU of Collaboration to Support Science & Technology Development 3Health News:New Compounding Pharmacy Videos Provide Product Information, Teach Safety 2Health News:New Compounding Pharmacy Videos Provide Product Information, Teach Safety 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: